Assenagon Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-645,020
| Closed | -$6.41M | – | 1279 |
|
|
2023
Q1 | $6.41M | Hold |
645,020
| – | – | 0.02% | 480 |
|
|
2022
Q4 | $4.49M | Sell |
645,020
-450
| -0.1% | -$3.13K | 0.02% | 529 |
|
|
2022
Q3 | $3.45M | Sell |
645,470
-1,347
| -0.2% | -$7.19K | 0.01% | 545 |
|
|
2022
Q2 | $2.58M | Sell |
646,817
-328,322
| -34% | -$1.31M | 0.01% | 713 |
|
|
2022
Q1 | $4.33M | Buy |
975,139
+948,747
| +3,595% | +$4.22M | 0.01% | 531 |
|
|
2021
Q4 | $106K | Sell |
26,392
-42,827
| -62% | -$172K | ﹤0.01% | 1348 |
|
|
2021
Q3 | $608K | Sell |
69,219
-569,094
| -89% | -$5M | ﹤0.01% | 982 |
|
|
2021
Q2 | $7.23M | Buy |
638,313
+584,539
| +1,087% | +$6.62M | 0.02% | 374 |
|
|
2021
Q1 | $639K | Sell |
53,774
-215,409
| -80% | -$2.56M | ﹤0.01% | 959 |
|
|
2020
Q4 | $1.85M | Sell |
269,183
-205,093
| -43% | -$1.41M | 0.01% | 509 |
|
|
2020
Q3 | $3.51M | Buy |
+474,276
| New | +$3.51M | 0.02% | 402 |
|